BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11596159)

  • 1. Diabetes mellitus and cystic fibrosis: comparison of clinical parameters in patients treated with insulin versus oral glucose-lowering agents.
    Rosenecker J; Eichler I; Bärmeier H; von der Hardt H
    Pediatr Pulmonol; 2001 Nov; 32(5):351-5. PubMed ID: 11596159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The course of glucose intolerance in children with cystic fibrosis: a retrospective study - preliminary report.
    Piechowiak K; Trippenbach-Dulska H; Walicka-Serzysko K
    Dev Period Med; 2015; 19(1):80-91. PubMed ID: 26003073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Open randomised prospective comparative multi-centre intervention study of patients with cystic fibrosis and early diagnosed diabetes mellitus.
    Ballmann M; Hubert D; Assael BM; Kronfeld K; Honer M; Holl RW;
    BMC Pediatr; 2014 Mar; 14():70. PubMed ID: 24620855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological management of cystic fibrosis related diabetes.
    Moheet A; Moran A
    Expert Rev Clin Pharmacol; 2018 Feb; 11(2):185-191. PubMed ID: 29268054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic fibrosis related diabetes (CFRD)--the end stage of progressive insulin deficiency.
    Hameed S; Jaffé A; Verge CF
    Pediatr Pulmonol; 2011 Aug; 46(8):747-60. PubMed ID: 21626717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic fibrosis related diabetes: Medical management.
    Ode KL; Chan CL; Granados A; Moheet A; Moran A; Brennan AL
    J Cyst Fibros; 2019 Oct; 18 Suppl 2():S10-S18. PubMed ID: 31679720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy of diabetes in cystic fibrosis patients.
    Hardin DS
    Expert Opin Pharmacother; 2010 Apr; 11(5):771-8. PubMed ID: 20166842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystic fibrosis-related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy.
    Rolon MA; Benali K; Munck A; Navarro J; Clement A; Tubiana-Rufi N; Czernichow P; Polak M
    Acta Paediatr; 2001 Aug; 90(8):860-7. PubMed ID: 11529531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of cystic fibrosis-related diabetes with type 1 diabetes based on a German/Austrian Pediatric Diabetes Registry.
    Konrad K; Thon A; Fritsch M; Fröhlich-Reiterer E; Lilienthal E; Wudy SA; Holl RW;
    Diabetes Care; 2013 Apr; 36(4):879-86. PubMed ID: 23238661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystic-fibrosis related-diabetes (CFRD) is preceded by and associated with growth failure and deteriorating lung function.
    Terliesner N; Vogel M; Steighardt A; Gausche R; Henn C; Hentschel J; Kapellen T; Klamt S; Gebhardt J; Kiess W; Prenzel F
    J Pediatr Endocrinol Metab; 2017 Aug; 30(8):815-821. PubMed ID: 28245190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose intolerance in cystic fibrosis patients.
    Lanng S
    Paediatr Respir Rev; 2001 Sep; 2(3):253-9. PubMed ID: 12052327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial.
    Moran A; Pekow P; Grover P; Zorn M; Slovis B; Pilewski J; Tullis E; Liou TG; Allen H;
    Diabetes Care; 2009 Oct; 32(10):1783-8. PubMed ID: 19592632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between insulin secretion, the insulin-like growth factor axis and growth in children with cystic fibrosis.
    Ripa P; Robertson I; Cowley D; Harris M; Masters IB; Cotterill AM
    Clin Endocrinol (Oxf); 2002 Mar; 56(3):383-9. PubMed ID: 11940051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic Fibrosis-Related Diabetes in Children: An Update.
    Kim RJ
    Pediatr Ann; 2016 Sep; 45(9):e321-6. PubMed ID: 27622916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CF-related diabetes: Containing the metabolic miscreant of cystic fibrosis.
    Moheet A; Moran A
    Pediatr Pulmonol; 2017 Nov; 52(S48):S37-S43. PubMed ID: 28714601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remission of severe neonatal diabetes with very early sulfonylurea treatment.
    Marshall BA; Green RP; Wambach J; White NH; Remedi MS; Nichols CG
    Diabetes Care; 2015 Mar; 38(3):e38-9. PubMed ID: 25715421
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanisms of glucose intolerance in cystic fibrosis.
    Mohan K; Miller H; Dyce P; Grainger R; Hughes R; Vora J; Ledson M; Walshaw M
    Diabet Med; 2009 Jun; 26(6):582-8. PubMed ID: 19538232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes and Prediabetes in Children With Cystic Fibrosis: A Systematic Review of the Literature and Recommendations of the Italian Society for Pediatric Endocrinology and Diabetes (ISPED).
    Mozzillo E; Franceschi R; Piona C; Passanisi S; Casertano A; Pjetraj D; Maltoni G; Calcaterra V; Cauvin V; Cherubini V; D'Annunzio G; Franzese A; Frongia AP; Lombardo F; Lo Presti D; Matteoli MC; Piccinno E; Predieri B; Rabbone I; Scaramuzza AE; Toni S; Zucchini S; Maffeis C; Schiaffini R
    Front Endocrinol (Lausanne); 2021; 12():673539. PubMed ID: 34017312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
    Tattersall RB
    Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219
    [No Abstract]   [Full Text] [Related]  

  • 20. Diabetic keto-acidosis as a presentation of cystic fibrosis-related diabetes: a case report.
    Eenkhoorn V; Van den Driessche A; Van Gaal L; Desager K; De Block C
    J Diabetes Complications; 2011; 25(2):137-41. PubMed ID: 20656523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.